Clearing the US and EU Regulatory Path to Product Approval – “What Similarities and Differences Exist and How Can Companies Manage the Hurdles?”

Learn how to navigate through the complexities and policy changes that biotech and nanotech products face today. Expert advice and case studies will provide valuable lessons on how policy and regulation is influencing technology in the US and EU and what companies can do to save time and cost throughout the process. Do regulatory agencies have the legal authority to make judgments on nanomaterials? Are they ready for this responsibility?

NANOTEC2008 will show how nanotechnology can lead to the development of a new generation of products, devices and processes which can revolutionise sectors of great relevance. The agenda will mirror the objectives of the Strategic Programme launched by the Italian Government, Industry 2015, which focus also on themes that are at the front line at world level:

• Energy efficiency;
• Sustainable mobility;
• New technologies for life sciences;
• New technologies for Made in Italy;
• Innovative technologies to preserve the cultural heritage.

Altair Nanotechnologies Inc. (Nasdaq: ALTI), a provider of advanced nanomaterial-based products